ScholarIQanswers from OpenAlex & ORCID
Franck Bonnetain
ResearcherPublications, citations & collaboration network
Franck Bonnetain is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Franck Bonnetain have?
ScholarIQindexed works
Franck Bonnetain has 544 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Franck Bonnetain have?
ScholarIQcitation count
Franck Bonnetain has 18,844 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Franck Bonnetain?
ScholarIQh-index
Franck Bonnetain has an h-index of 66 in OpenAlex.
What is the i10-index of Franck Bonnetain?
ScholarIQi10-index
Franck Bonnetain has an i10-index of 228 in OpenAlex.
What is the OpenAlex record for Franck Bonnetain?
ScholarIQopenalex
The OpenAlex for Franck Bonnetain is on the source record.
What are the most-cited papers on Franck Bonnetain?
ScholarIQmost cited works
Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer
C. Mariette, Sheraz R. Markar, Tienhan Sandrine Dabakuyo‐Yonli, Bernard Meunier, Denis Pezet, Denis Collet, Xavier Benoît D’Journo, Cécile Brigand, T Perniceni, Nicolas Carrère, Jean‐Yves Mabrut, Simon Msika, Frédérique Peschaud, Michel Prudhomme, Franck Bonnetain, Guillaume Piessen
Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials
Vincenzo Valentini, Ruud G.P.M. van Stiphout, Guido Lammering, Maria Antonietta Gambacorta, Marta Barba, Marek Bębenek, Franck Bonnetain, J.F. Bosset, Krzysztof Bujko, L. Cionini, Jean‐Pierre Gérard, Claus Rödel, A. Sainato, Rolf Sauer, Bruce D. Minsky, Laurence Collette, Philippe Lambin
Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial
Thierry André, Déwi Vernerey, Laurent Mineur, Jaafar Bennouna, Jérôme Desrame, Roger Faroux, Serge Fratté, Marine Hug de Larauze, Sophie Paget‐Bailly, Benoist Chibaudel, Jérémie Bez, Jérôme Dauba, Christophe Louvet, Céline Lepère, Olivier Dupuis, Y. Bécouarn, May Mabro, Joëlle Egreteau, Olivier Bouché, G. Deplanque, Marc Ychou, Marie Pierre Galais, François Ghiringhelli, Louis Marie Dourthe, Jean‐Baptiste Bachet, Ahmed Khalil, Franck Bonnetain, Aimery de Gramont, Julien Taı̈eb, for PRODIGE investigators, GERCOR, Fédération Française de Cancérologie Digestive, and UNICANCER
Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial
Nicolas Briez, Guillaume Piessen, Franck Bonnetain, Cécile Brigand, Nicolas Carrère, Denis Collet, C. Doddoli, Renaud Flamein, Jean‐Yves Mabrut, Bernard Meunier, Simon Msika, T Perniceni, Frédérique Peschaud, Michel Prudhomme, Jean–Pierre Triboulet, C. Mariette
Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study
David Tougeron, Guillaume Mouillet, Isabelle Trouilloud, Thierry Lecomte, Romain Coriat, Thomas Aparicio, G. Des Guetz, Cédric Lecaille, Pascal Artru, Gaëlle Sickersen, Estelle Cauchin, David Sefrioui, Tarek Boussaha, Aurélie Ferru, Tamara Matysiak‐Budnik, Christine Silvain, Lucie Karayan‐Tapon, Jean‐Christophe Pagès, Déwi Vernerey, Franck Bonnetain, Pierre Michel, Julien Taı̈eb, Aziz Zaanan